ELECTROCARDIOGRAM MONITORING CLEARED FOR GALAXY WATCH ACTIVE2

Samsung Electronics announced that the Electrocardiogram (ECG) function of the Samsung Health Monitor app has been cleared by South Korea’s Ministry of Food and Drug Safety (MFDS). The ECG feature uses advanced sensor technology on the Galaxy Watch Active2, and will enable users to measure and analyze their heart rhythm for irregularities indicating Atrial Fibrillation (AFib).


“We’re delighted to announce that the ECG function has been cleared by MFDS,” said TaeJong Jay Yang, Corporate SVP and Head of Health Team, Mobile Communications Business at Samsung Electronics. “When you pair the advanced hardware of Galaxy watches with innovative software solutions, you can create unmatched experiences – such as in this case, convenient and accessible health check-ins for millions of users across the world. This marks just one way in which Samsung is pioneering to give everyone a simple, convenient and informed picture of their overall health and wellness.”

AFib is the most common abnormal heart rhythm, affecting an estimated 33.5 million people worldwide, with 5 million new patients diagnosed annually. It can significantly increase the risk of complications, including blood clots, heart failure and stroke. Every year, over 16 million people will develop a stroke, of which AFib and high blood pressure (hypertension), are known to be the leading causes.


The Samsung Health Monitor app also recently received MFDS clearance for blood pressure (BP) measurement, meaning users will be able to conveniently measure both ECG and BP, giving them a better picture of their overall health. Together, the ground-breaking ECG and BP technology will help users manage and improve their health by providing on-demand measurements.

Register for Newsletter

  • LinkedIn
  • Instagram
  • YouTube

WHERE BUSINESS CLICKS

@2020 by The Financial District